AOC 1072
Alternative Names: AOC-1072Latest Information Update: 08 Jan 2025
Price :
$50 *
At a glance
- Originator Avidity Biosciences
- Class Cardiovascular therapies; Drug conjugates; Immunoconjugates; Monoclonal antibodies; Oligonucleotides; Small interfering RNA
- Mechanism of Action AMP activated protein kinase inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cardiomyopathies